GOVX new logo.png
GeoVax Announces Upcoming Presentation of Lassa Fever Vaccine Data
July 16, 2019 09:00 ET | GeoVax, Inc.
ATLANTA, GA, July 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company specializing in developing human vaccines, announced today that Senior...
299982_GeoVaxLogo.jpg
GeoVax to Present at the American Society for Virology 2018 Annual Meeting
July 09, 2018 09:00 ET | GeoVax, Inc.
ATLANTA, GA, July 09, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), winner of the 2018 “Best Biotech” at the Vaccine Industry Excellence (ViE) Awards during the World Vaccine Congress,...